🔎 Trials Near Me

Pradžia › Uždegiminė žarnyno liga › Masčusetsas

Uždegiminė žarnyno liga klinikiniai tyrimai Masčusetsas

15 tyrimai dėl Uždegiminė žarnyno liga ieško dalyvių vietose Masčusetsas.

Miestai Masčusetsas

Oficialus tyrimo tekstas (anglų kalba)

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

  • Massachusetts General Hospital, Boston
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07033208

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 003, Boston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07012395

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Boston Childrens Hospital, Boston
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-25 · NCT05923073

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Boston Children's Hospital, Boston
  • Massachusetts General Hospital, Waltham
Renkami dalyviai3 fazė
Amžius nuo 2 iki 19 · Visoms lytims · Atnaujinta 2026-09-22 · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Boston Children's Hospital, Boston
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-08-24 · NCT05509777

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • Brigham and Women's Hospital, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07237516

Low Dose IL-2 for the Treatment of Crohn's Disease

  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Renkami dalyviai1/2 fazė
Amžius nuo 12 iki 80 · Visoms lytims · Atnaujinta 2026-08-03 · NCT04263831

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Boston Children's Hospital, Boston
Renkami dalyviai4 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-05-27 · NCT05781152

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

  • Massachusetts General Hospital, Boston
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 14 ir vyresni · Visoms lytims · Atnaujinta 2026-01-30 · NCT05332639

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

  • Massachusetts General Hospital, Boston
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2025-12-16 · NCT07219537

Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis

  • Massachusetts General Hospital, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-11-06 · NCT07168499

Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • Boston Children's Hospital, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 13 iki 20 · Visoms lytims · Atnaujinta 2025-10-30 · NCT04508088

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

  • Boston Children's Hospital, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 5 iki 25 · Visoms lytims · Atnaujinta 2025-03-03 · NCT04331639

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

  • Massachusetts General Hospital, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 14 ir vyresni · Visoms lytims · Atnaujinta 2024-12-20 · NCT06655415

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.